• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.10% Nasdaq Down 1.82%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    35.58 Down 1.09(2.97%) Feb 8, 4:00PM EST
    Prev Close:36.67
    Open:36.01
    Bid:29.60 x 100
    Ask:200,000.00 x 100
    1y Target Est:47.67
    Beta:1.57462
    Next Earnings Date:11-Feb-16ACOR Earnings announcement
    Day's Range:34.54 - 36.75
    52wk Range:25.50 - 43.63
    Volume:572,646
    Avg Vol (3m):610,961
    Market Cap:1.54B
    P/E (ttm):684.23
    EPS (ttm):0.05
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACOR

    Comparison

    Symbol% ChgMkt Cap
    ACORDown 2.97%1.54B
    BIIBDown 4.96%54.84B

    Key Statistics

    Forward P/E (1 yr):34.88
    P/S (ttm):3.28
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :1.00
    Quarterly EPS Est (Dec-15) :0.22
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):1.29

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback